Premium
Serum predominantly activates MAPK and Akt kinases in EGFR‐ and ErbB2‐over‐expressing cells, respectively
Author(s) -
Tari Ana Maria,
LopezBerestein Gabriel
Publication year - 2000
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(20000415)86:2<295::aid-ijc22>3.0.co;2-k
Subject(s) - erbb3 , autophosphorylation , grb2 , erbb , protein kinase b , mapk/erk pathway , receptor tyrosine kinase , epidermal growth factor , signal transduction , signal transducing adaptor protein , growth factor receptor , epidermal growth factor receptor , microbiology and biotechnology , cancer research , tyrosine kinase , kinase , biology , chemistry , receptor , biochemistry , protein kinase a